Phreesia, Inc. (PHR) has a MoatMap StockRank of 41/100 based on Quality (60/100), Value (45/100), and Momentum (22/100) factor scores. The current signal is HOLD. Phreesia provides useful patient intake software but lacks a clear path to high, sustainable profitability and does not align with our active macro themes.
Phreesia provides a leading SaaS-based patient intake and payment platform that automates registration, scheduling, and billing for healthcare organizations. The company's platform is deeply integrated into major electronic health record (EHR) systems, creating high switching costs and a highly recurring subscription revenue model. Its unique point-of-care network also allows pharmaceutical companies to deliver targeted digital campaigns directly to patients, creating a high-margin secondary revenue stream.
| Price | $9.29 |
| Market Cap | $584M |
| P/E (TTM) | 60.56 |
| P/E (Forward) | 6.06 |
| Price/Book | 1.67 |
| Return on Equity | 2.9% |
| Return on Invested Capital | -0.4% |
| Debt/Equity | 25.77 |
| Gross Margin | 67.8% |
| Operating Margin | 5.2% |
| Revenue Growth | 12.9% |
| Free Cash Flow | $56M |
Phreesia, Inc. operates in the Health Information Services industry, part of the Healthcare sector (United States).